Biomedical Engineering Reference
In-Depth Information
too can be treated along with the visible telangiectasia. One
could imagine in the future the patient placing the leg into a
laser machine that would map the visible veins to be thermo-
coagulated and automatically treat the entire superfi cial
venous network. At this time, the only barrier preventing the
development of such a laser is money and the willingness of a
company to produce a machine of this type.
15. McDaniel DH, Ash K, Lord J, et al. Laser therapy of spider leg veins:
clinical evaluation of a new long pulsed alexandrite laser. Dermatol Surg
1999; 25: 52.
16. Izikson L, Nelson JS, Anderson RR. Treatment of hypertrophic and
resistant port wine stains with a 755-nm laser: A case series of 20 patients.
Lasers Surg Med 2009; 41: 427.
17. Dierickx CC, Dugue V, Anderson RR. Treatment of leg telangiectasia by a
pulsed 800nm diode laser. Presented at the 18th Annual Meeting of the
American Society of Laser Medicine and Surgery. San Diego, Calif, April 5-7,
1998.
18. Trelles MA, Allones I, Álvarez J, et al. The 800-nm diode laser in the
treatment of leg veins: Assessment at 6 months. J Am Acad Dermatol
2006; 54: 282.
19. Prieto V, Zhang P, Sadick NS. Comparison of a combination diode laser
and radiofrequency device (Polaris®) and a long-pulsed 1064-nm Nd:YAG
laser (Lyra®) on leg telangiectases. Histologic and immunohistochemical
analysis. J Cosmet Laser Ther 2006; 8: 191.
20. Glassberg E, Lask GP, Tan EM, et al. The fl ashlamp-pumped 577-nm
pulsed tunable dye laser: clinical effi cacy and in vitro studies. J Dermatol
Surg Oncol 1988; 14: 1200.
21. Black JF, Wade N, Barton JK. Mechanistic comparison of blood
undergoing laser photocoagulation at 532 and 1,064 nm. Lasers Surg Med
2005; 36: 155.
22. Munia MA, Wolosker N, Munia CG, Puech-Leao P. Comparison of laser
versus sclerotherapy in the treatment of lower extremity telangiectases: a
prospective study. Dermatol Surg 2012; 38: 635.
23. Weiss RA, Weiss MA. Photothermal sclerosis of resistant telangiectatic leg
and facial veins using the PhotoDerm VL. Presented at the Annual
Meeting of the Mexican Academy of Dermatology. Monterey, Mexico,
April 24, 1996.
24. Corcos L, Longo L. Classifi cation and treatment of telangiectases of the
lower limbs. Laser 1988; 1: 22.
25. Goldman MP. Are lasers or non-coherent light sources the treatment of
choice for leg veins? A look into the future. Cosmet Dermatol 2001; 14: 58.
26. Goldman MP. Cosmetic and Cutaneous Laser Surgery. Elsevier: Philadelphia
and THE Aesthetic Guide Primary Care Edition Autumn 2008, 2006:
[Available from: www.miinews.com]
27. Anderson RA. Annual Meeting of the North American Society of
Phlebology. Washington, DC, November, 1996.
28. Goldman MP, Weiss RA, Bergan JJ, eds. Varicose Veins and Telangiectasia:
Diagnosis and Treatment. St Louis: Quality Medical Publishers, 1999.
29. West TB, Alster TS. Comparison of the long-pulsed dye and KTP lasers in
the treatment of facial and leg telangiectasia. Dermatol Surg 1998; 24: 221.
30. Goldman MP, Guex JJ, Weiss RA, eds. Sclerotherapy Treatment of Varicose
and Telangiectatic Leg Veins, 5th edn. London: Elsevier, Inc, 2011.
references
1. Dover JS, Sadick NS, Goldman MP. The role of lasers and light sources in
the treatment of leg veins. Dermatol Surg 1999; 25: 328.
2. Ross EV, Domankevitz Y. Laser treatment of leg veins: physical mechanisms
and theoretical considerations. Lasers Surg Med 2005; 36: 105.
3. Kunishige JH, Goldberg LH, Friedman PM. Laser therapy for leg veins.
Clin Dermatol 2007; 25: 454.
4. Weiss RA, Weiss MA. Resolution of pain associated with varicose and
telangiectatic leg veins after compression sclerotherapy. J Dermatol Surg
Oncol 1990; 16: 333.
5. Bernstein EF. Clinical characteristics of 500 consecutive patients
presenting for removal of lower extremity spider veins. Dermatol Surg
2001; 27: 31.
6. Goldman MP, Kaplan RP, Duffy DM. Postsclerotherapy hyper-
pigmentation: a histologic evaluation. J Dermatol Surg Oncol 1987; 13: 547.
7. Duffy DM. Small vessel sclerotherapy: an overview. In: Callen JP, et al. eds.
Advances in Dermatology. Chicago: Year Book Medical Publishers, 1988.
8. De Faria JL, Moraes IN. Histopathology of the telangiectasias associated
with varicose veins. Dermatologia 1963; 127: 321.
9. Goldman MP. Laser and sclerotherapy treatment of leg veins: my
perspective on treatment outcomes. Dermatol Surg 2002; 28: 969.
10. Polla LL, Tan OT, Garden JM, Parrish JA. Tunable pulsed dye laser for
the treatment of benign cutaneous vascular ectasia. Dermatologica 1987;
174: 11.
11. Perez B, Nunez M, Boixeda P, et al. Progressive ascending telangiectasia
treated with the 585nm fl ashlamp-pumped pulsed dye laser. Lasers Surg
Med 1997; 21: 413.
12. Fajardo LF, Prionas SD, Kowalski J, Kwan HH. Hyperthermia inhibits
angiogenesis. Radiat Res 1988; 114: 297.
13. Sadick NS, Sorhaindo L. An evaluation of post-sclerotherapy laser
compression and its effi cacy in the treatment of leg telangiectasias.
Phlebology 2006; 21: 191.
14. Adrian RM. Long pulse normal mode alexandrite laser treatment of leg
veins. Presented at the 18th Annual Meeting of the American Society of
Laser Medicine and Surgery. San Diego, CA, April 5-7, 1998.
